Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies
Files in This Item:
|Advances in dynamic modeling of colorectal cancer signaling Network...pdf||2.95 MB||Adobe PDF||Download|
|Title:||Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies||Authors:||Tortolina, Lorenzo
Duffy, David J.
Carmody, Aimee M.
Kholodenko, Boris N.
|Permanent link:||http://hdl.handle.net/10197/9790||Date:||31-Dec-2014||Online since:||2019-04-03T10:29:43Z||Abstract:||The interconnected network of pathways downstream of the TGFβ, WNT and EGF-families of receptor ligands play an important role in colorectal cancer pathogenesis. We studied and implemented dynamic simulations of multiple downstream pathways and described the section of the signaling network considered as a Molecular Interaction Map (MIM). Our simulations used Ordinary Differential Equations (ODEs), which involved 447 reactants and their interactions. Starting from an initial "physiologic condition", the model can be adapted to simulate individual pathologic cancer conditions implementing alterations/mutations in relevant onco-proteins. We verified some salient model predictions using the mutated colorectal cancer lines HCT116 and HT29. We measured the amount of MYC and CCND1 mRNAs and AKT and ERK phosphorylated proteins, in response to individual or combination onco-protein inhibitor treatments. Experimental and simulation results were well correlated. Recent independently published results were also predicted by our model. Even in the presence of an approximate and incomplete signaling network information, a predictive dynamic modeling seems already possible. An important long term road seems to be open and can be pursued further, by incremental steps, toward even larger and better parameterized MIMs. Personalized treatment strategies with rational associations of signaling-proteins inhibitors, could become a realistic goal.||Funding Details:||European Commission - Seventh Framework Programme (FP7)
Irish Research Council
Science Foundation Ireland
University College Dublin
|Type of material:||Journal Article||Publisher:||Impact Journals||Journal:||Oncotarget||Volume:||6||Issue:||7||Start page:||5041||End page:||5058||Copyright (published version):||2014 the Authors||Keywords:||Colorectal cancer; Target therapies; Signaling-network; Dynamic modeling; Onco-protein inhibitors||DOI:||10.18632/oncotarget.3238
|Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
SBI Research Collection
Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.